PR Newswire Clinical TrialsOriginal article
Response Media launches RE:HEALTH to Address Pharma's $300 Billion Adherence Blind Spot¹
Positive
AI Analysis
Summary
Response Media launched RE:HEALTH, a new health and life sciences practice, and introduced AdherenceIQ, an AI-powered platform designed to predict patient adherence risk. The initiative addresses the estimated $300 billion annual cost of medication nonadherence in the U.S. healthcare system.
Importance:3/10
Sentiment:
0.50
patient_adherenceAI_platformhealthcare_costsmedication_nonadherence
Read the original article
Published by PR Newswire Clinical Trials on September 10, 2026 2:38 PM
